TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES Share Price

Certificat

DE000SQ2CNZ1

Market Closed - Deutsche Boerse AG 20:44:10 05/06/2024 BST
2.07 EUR -0.48% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES
Current month+7.81%
1 month-14.11%
Date Price Change
05/06/24 2.07 -0.48%
04/06/24 2.08 +1.96%
03/06/24 2.04 +6.25%
31/05/24 1.92 -1.54%
30/05/24 1.95 +3.17%

Delayed Quote Deutsche Boerse AG

Last update June 05, 2024 at 08:44 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ2CNZ
ISINDE000SQ2CNZ1
Date issued 29/09/2022
Strike 80.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.99
Lowest since issue 1.3

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.2 USD
Average target price
125.4 USD
Spread / Average Target
+21.45%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW